Cooper Companies Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 4/6
Cooper Companies şirketinin kazançları yıllık ortalama -14.7% oranında azalırken, Medical Equipment sektörünün kazançları yıllık 13.1% oranında artan oldu. Gelirler yıllık ortalama 9.4% oranında artan oldu. Cooper Companies şirketinin öz sermaye getirisi 4.5% olup, net marjı 9.4% dir.
Anahtar bilgiler
-14.7%
Kazanç büyüme oranı
-14.8%
EPS büyüme oranı
Medical Equipment Sektör Büyümesi | 8.9% |
Gelir büyüme oranı | 9.4% |
Özkaynak getirisi | 4.5% |
Net Marj | 9.4% |
Sonraki Kazanç Güncellemesi | 05 Dec 2024 |
Yakın geçmiş performans güncellemeleri
Recent updates
The Cooper Companies: Winning Share In Contact Lens Markets
Oct 09Are Investors Undervaluing The Cooper Companies, Inc. (NASDAQ:COO) By 35%?
Oct 01Returns On Capital At Cooper Companies (NASDAQ:COO) Paint A Concerning Picture
Sep 15The Cooper Companies: Still An Expensive Place
Aug 26Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
May 21With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
May 02Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Nov 30Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
Oct 30What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?
Sep 28Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly
Sep 10Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Aug 23Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return
Jul 24The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?
Jun 24Is Cooper Companies (NYSE:COO) Using Too Much Debt?
Jun 08Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)
May 24Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Apr 23At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?
Mar 25These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well
Feb 04Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Jan 19Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Jan 04Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?
Dec 20The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?
Oct 18BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health
Oct 18Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital
Oct 03Gelir ve Gider Dağılımı
Cooper Companies nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
---|---|---|---|---|
31 Jul 24 | 3,804 | 359 | 1,527 | 154 |
30 Apr 24 | 3,732 | 340 | 1,521 | 152 |
31 Jan 24 | 3,666 | 291 | 1,580 | 145 |
31 Oct 23 | 3,593 | 294 | 1,530 | 137 |
31 Jul 23 | 3,514 | 275 | 1,488 | 130 |
30 Apr 23 | 3,427 | 288 | 1,467 | 122 |
31 Jan 23 | 3,380 | 375 | 1,350 | 116 |
31 Oct 22 | 3,308 | 386 | 1,338 | 110 |
31 Jul 22 | 3,219 | 431 | 1,297 | 107 |
30 Apr 22 | 3,139 | 948 | 1,238 | 103 |
31 Jan 22 | 3,029 | 939 | 1,205 | 98 |
31 Oct 21 | 2,923 | 2,945 | 1,142 | 93 |
31 Jul 21 | 2,845 | 2,916 | 1,122 | 93 |
30 Apr 21 | 2,660 | 2,355 | 1,054 | 90 |
31 Jan 21 | 2,465 | 2,249 | 997 | 93 |
31 Oct 20 | 2,431 | 238 | 991 | 93 |
31 Jul 20 | 2,441 | 278 | 937 | 91 |
30 Apr 20 | 2,542 | 343 | 972 | 91 |
31 Jan 20 | 2,672 | 454 | 981 | 88 |
31 Oct 19 | 2,653 | 467 | 993 | 87 |
31 Jul 19 | 2,613 | 446 | 981 | 86 |
30 Apr 19 | 2,594 | 427 | 957 | 87 |
31 Jan 19 | 2,571 | 366 | 944 | 87 |
31 Oct 18 | 2,533 | 140 | 973 | 85 |
31 Jul 18 | 2,443 | 128 | 907 | 81 |
30 Apr 18 | 2,339 | 131 | 864 | 76 |
31 Jan 18 | 2,230 | 175 | 823 | 72 |
31 Oct 17 | 2,139 | 373 | 799 | 69 |
31 Jul 17 | 2,096 | 345 | 756 | 68 |
30 Apr 17 | 2,055 | 329 | 739 | 67 |
31 Jan 17 | 2,016 | 298 | 726 | 67 |
31 Oct 16 | 1,967 | 274 | 711 | 65 |
31 Jul 16 | 1,904 | 250 | 679 | 63 |
30 Apr 16 | 1,851 | 207 | 666 | 64 |
31 Jan 16 | 1,801 | 194 | 656 | 64 |
31 Oct 15 | 1,797 | 204 | 661 | 65 |
31 Jul 15 | 1,810 | 198 | 659 | 67 |
30 Apr 15 | 1,780 | 241 | 655 | 66 |
31 Jan 15 | 1,758 | 259 | 648 | 66 |
31 Oct 14 | 1,718 | 270 | 639 | 66 |
31 Jul 14 | 1,661 | 296 | 632 | 64 |
30 Apr 14 | 1,640 | 297 | 623 | 63 |
31 Jan 14 | 1,611 | 293 | 618 | 61 |
Kaliteli Kazançlar: COO yüksek kaliteli kazançlar sağlıyor.
Büyüyen Kar Marjı: COO 'nin mevcut net kar marjları (9.4%) geçen yılın (7.8%) sinden daha yüksektir.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: COO şirketinin kazançları son 5 yılda yılda 14.7% oranında azaldı.
Büyüme Hızlandırma: COO 'un son bir yıldaki kazanç büyümesi ( 30.5% ) 5 yıllık ortalamasını (yıllık -14.7% ) aşıyor.
Kazançlar vs. Sektör: COO geçen yılki kazanç büyümesi ( 30.5% ) Medical Equipment sektörünün 11.7% değerini aştı.
Özkaynak Getirisi
Yüksek ROE: COO 'nin Özsermaye Getirisi ( 4.5% ) düşük olarak değerlendiriliyor.